Kate is interested in the relationship between substance use and adverse health and social outcomes. She is involved in the MRC PROGnosis Research Strategy Partnership (www.progress-partnership.org), which aims to develop and promote research into quality of care outcomes, prognostic factors, and risk prediction models. She is also interested in the analytical and policy challenges raised by research involving large-scale data sets, such as those generated by genomic studies or linked electronic records projects.
Kate did her PhD research on genetic and environmental influences on smoking at the University of Queensland and the Queensland Institute of Medical Research in Australia, graduating in 2007. She then became a NHMRC Post-doctoral Training Fellow at the University of Melbourne, jointly based at the Centre for Molecular, Environmental, Genetic and Analytic Epidemiology and the Orygen Centre for Youth Mental Health. In 2009 Kate left Australia for the UK and the Department of Human Genetics at the Wellcome Trust Sanger Institute. There she worked on computational and statistical genetics projects for a number of years before moving to the Farr Institute of Health Informatics Research at University College London, and then to the Institute of Psychiatry, Psychology & Neuroscience (IoPPN).